Unknown

Dataset Information

0

Prevalence of antiphospholipid antibodies in Behcet's disease: A systematic review and meta-analysis.


ABSTRACT: Behçet's disease (BD) is a multifactorial systemic inflammatory disease of unknown aetiology characterised by several clinical manifestations including vascular involvements (i.e., both arterial and venous thrombosis). Antiphospholipid antibodies (aPLs)-including anticardiolipin (aCL), anti-?2-glycoprotein I (?2-GPI) antibodies and lupus anticoagulant (LA) are detected in systemic autoimmune diseases which contribute to thrombosis. The aim of this systematic review and meta-analysis was to evaluate the prevalence of aPLs in patients with BD as compared to controls. A protocol was registered in PROSPERO (Registration No. CRD42018088125) and a systematic literature search was conducted through PubMed, Web of Science, Embase, Scopus and ScienceDirect databases. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using random-effects model. Quality assessment was carried out by using the modified 9-star Newcastle-Ottawa Scale (NOS). Publication bias was evaluated via visualisation of contour- enhanced and trim and fill funnel plots along with Begg's and Egger's tests. We included ten case-control studies (a total of 999 participants from 380 BD patients and 619 controls) based on the inclusion criteria. The prevalence of aCL (OR: 12.10, 95% CI: 5.15-28.41, p<0.00001) and anti-?2-GPI antibodies (OR: 23.57, 95% CI: 1.31-423.63, p = 0.03) were statistically significant, however, the prevalence of LA was not significant (OR: 13.77, 95% CI: 0.65-293.59, p = 0.09). The results remained statistically significant from different sensitivity analyses which represented the robustness of this meta-analysis. According to the NOS, 50.0% of the studies were considered as of high methodological quality (low risk of bias). No significant publication bias was detected from contour-enhanced and trim and fill funnel plots or Begg's and Egger's tests. This meta-analysis established that there is a significantly high prevalence of aPLs (i.e., aCL and anti-?2-GPI antibodies) in patients with BD when compared to controls.

SUBMITTER: Islam MA 

PROVIDER: S-EPMC6957187 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis.

Islam Md Asiful MA   Alam Sayeda Sadia SS   Kundu Shoumik S   Prodhan A H M Safayet Ullah AHMSU   Khandker Shahad Saif SS   Reshetnyak Tatiana T   Kotyla Przemysław J PJ   Hassan Rosline R   Hossan Tareq T  

PloS one 20200113 1


Behçet's disease (BD) is a multifactorial systemic inflammatory disease of unknown aetiology characterised by several clinical manifestations including vascular involvements (i.e., both arterial and venous thrombosis). Antiphospholipid antibodies (aPLs)-including anticardiolipin (aCL), anti-β2-glycoprotein I (β2-GPI) antibodies and lupus anticoagulant (LA) are detected in systemic autoimmune diseases which contribute to thrombosis. The aim of this systematic review and meta-analysis was to evalu  ...[more]

Similar Datasets

| S-EPMC7824385 | biostudies-literature
| S-EPMC5537149 | biostudies-literature
| S-EPMC6234954 | biostudies-literature
| S-EPMC8760269 | biostudies-literature
| S-EPMC4753467 | biostudies-literature
| S-EPMC6929502 | biostudies-literature
| S-EPMC8313333 | biostudies-literature
| S-EPMC8661824 | biostudies-literature
| S-EPMC9391168 | biostudies-literature
| 79216 | ecrin-mdr-crc